We don’t have direct confirmation either way, and MHRA correspondence isn’t public.
What we do have are public records. Under MHRA guidance, a CHM letter is only issued if major objections are raised. The CHM minutes show no major objections, no representations, and no follow-up actions.
At the ASM, management described ongoing MHRA engagement as cycles of questions and clarifications and said they could not predict timing. That disclosure is consistent with normal progression, not an active objections process.
Bullish
Market Data 
Markets 
AI
